US 6881420
Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
expired A61KA61K31/663A61K9/0065
Quick answer
US patent 6881420 (Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 19 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 14 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/663, A61K9/0065, A61K9/2027, A61K9/205